Baosheng Media Group Holdings Limited Ordinary shares (BAOS) Dividend History

Baosheng Media Group Holdings Limited is a digital marketing and advertising company based in China. It specializes in providing integrated marketing solutions, including media planning, digital advertising, and brand promotion services. The company leverages data-driven strategies and technology to connect brands with target audiences across various digital platforms.

Dividend History

Baosheng Media Group Holdings Limited Ordinary shares currently does not pay dividends

Company News

  • Trump Media & Technology Group shares jumped 69.4% in pre-market trading after the company's CEO issued a statement in response to an attempted assassination of former President Donald Trump. Several other stocks also saw significant pre-market movements.

    Benzinga
    Featured Companies: AGRI CGBS DJT LPA PETZ QLGN RUN
  • Beijing, China, May 31, 2024 (GLOBE NEWSWIRE) -- Baosheng Media Group Holdings Limited (NASDAQ: BAOS) (“Baosheng” or the “Company”), a China-based online marketing solution provider, today announced that on May 9, 2024, the Company filed a current report on Form 6-K with the U.S. Securities and Exchange Commission (the "SEC") regarding certain pending legal proceeding.

    GlobeNewswire Inc.
  • Shares of DouYu International Holdings Limited (NASDAQ: DOYU) rose sharply during Thursday’s session after announcing a share repurchase program. DouYu plans repurchase of up to $20 million of ordinary shares in the form of ADSS during period of up to twelve months commencing on Jan. 1, 2024. DouYu International shares jumped 14.2% to $0.8320 on Thursday. Here are some other stocks moving in today's mid-day session. Gainers Nova LifeStyle, Inc. (NASDAQ: NVFY) shares jumped 204% to $4.71. Cingulate Inc. (NASDAQ: CING) climbed 157.4% to $10.27. On Tuesday, Cingulate received FDA guidance for CTx-1301 (dexmethylphenidate), its lead investigational product candidate for attention deficit hyperactivity disorder (ADHD). Bone Biologics Corporation (NASDAQ: BBLG) gained 62.2% to $7.54. SenesTech, Inc. (NASDAQ: SNES) shares climbed 50.7% to $1.30. HC Wainwright & Co. analyst Amit Dayal maintained SenesTech with a Buy, adjusting target to $3.5 from $4. Microbot Medical Inc. (NASDAQ: MBOT) rose 38% to $1.8301 after the company announced the completion of its GLP pivotal pre-clinical study. Sidus Space, Inc. (NASDAQ: SIDU) gained 32% to $5.81. DatChat, Inc. (NASDAQ: DATS) rose 30% to $2.62. DatChat announced the release of its new AI social gaming platform and developer program for game designers and content creators. SEALSQ Corp (NASDAQ: LAES) gained 25% to $1.4424. SEALSQ disclosed that its post-quantum semiconductor technology, based on cutting-edge cryptographic algorithms, is specifically designed to withstand attacks from and secure cryptocurrency transactions against the looming threat of quantum computing. Ocean Biomedical, Inc. (NASDAQ: OCEA) surged 21.4% to $0.7299. DSS, Inc. (NYSE: DSS) jumped 21% to $0.1477. RenovoRx, Inc. (NASDAQ: RNXT) gained 20% to $1.2599. Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) rose 20% to $3.6250. The FDA recently approved the company's Zoryve topical foam, 0.3% for seborrheic dermatitis in individuals nine years and older. Envoy ...

    Benzinga
  • Shares of Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM) shares rose sharply during Wednesday’s session after Concentra sent an acquisition proposal to acquire 100% of equity of the company for $1.80 per share. Reneo Pharmaceuticals shares climbed 13.6% to $1.59 on Wednesday. Here are some other stocks moving in today's mid-day session. Gainers First Wave BioPharma, Inc. (NASDAQ: FWBI) shares jumped 169% to $9.90 after the company announced that it entered a non-binding term sheet to sell its Niclosamide program for the treatment of inflammatory bowel diseases. Cingulate Inc. (NASDAQ: CING) gained 95.2% to $4.08. RiskOn International, Inc. (NASDAQ: ROI) shares climbed 91.8% to $0.27. RiskOn International expects to announce its new generative AI platform and technology partner on Jan. 3, 2024. Cytokinetics, Incorporated (NASDAQ: CYTK) surged 64.2% to $75.05 after the company announced topline results from SEQUOIA-HCM, the Phase 3 clinical trial of aficamten in patients with symptomatic obstructive hypertrophic cardiomyopathy. AEye, Inc. (NASDAQ: LIDR) rose 61.2% to $3.58. Vince Holding Corp. (NYSE: VNCE) jumped 42% to $3.2399. Bit Brother Limited(NASDAQ: BETS) gained 38.2% to $0.0152 after jumping 111% on Tuesday. Nxu, Inc. (NASDAQ: NXU) rose 34% to $4.18. Virax Biolabs Group Limited (NASDAQ: VRAX) gained 32% to $1.7551. Jet.AI Inc. (NASDAQ: JTAI) shares gained 28% to $2.05 after falling 39% on Tuesday. Elicio Therapeutics, Inc. (NASDAQ: ELTX) jumped 25% to $8.89. Elicio Therapeutics 10% owner GKCC, LLC acquired a total of 1,213,000 shares an average price of $5.81. Matinas BioPharma Holdings, Inc. (NASDAQ: MTNB) gained 24.7% to ...

    Benzinga
  • U.S. stocks traded slightly higher this morning, with the Dow Jones index gaining more than 20 points on Wednesday. Following the market opening Wednesday, the Dow traded up 0.08% to 37,575.13 while the NASDAQ rose 0.17% to 15,099.84. The S&P 500 also rose, gaining, 0.07% to 4,777.93. Check This Out: Over $2M Bet On This Energy Stock? Check Out These 3 Stocks Insiders Are Buying   Leading and Lagging Sectors   Consumer discretionary shares jumped by 0.5% on Wednesday. In trading on Wednesday, financial shares fell by 0.2%.   Top Headline   Coherus BioSciences, Inc. (NASDAQ: CHRS) announced FDA approval of UDENYCA ONBODY for pegfilgrastim-cbqv.   Equities Trading UP   First Wave BioPharma, Inc. (NASDAQ: FWBI) shares shot up 236% to $12.35 after the company announced that it entered a non-binding term sheet to sell its Niclosamide program for the treatment of inflammatory bowel diseases. Shares of Cingulate Inc. (NASDAQ:

    Benzinga
    Featured Companies: CHRS CING IOVA
Dividend data last updated 06/07/2025 11:07:16 UTC